Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?-Reference-Cited by-同舟云学术

Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Published:2014-09-18 Issue:12 Volume:68 Page:1429-1441
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Citrome L.¹

Affiliation:

1. New York Medical College; Valhalla NY USA

Publisher

Hindawi Limited

Subject

General Medicine

Reference41 articles.

1. Insomnia;Deak;Neurol Clin,2012

2. Epidemiology of insomnia: what we know and what we still need to learn;Ohayon;Sleep Med Rev,2002

3. Comorbidity of chronic insomnia with medical problems;Taylor;Sleep,2007

4. Diagnostic and Statistical Manual of Mental Disorders

5. Epidemiology of insomnia, depression, and anxiety;Taylor;Sleep,2005

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orexin-mediated motivated arousal and reward seeking;Peptides;2024-10

2. Incorporation of suvorexant and lemborexant into hair and their distributions after a single intake;Forensic Toxicology;2024-08-09

3. Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed;Postgraduate Medicine;2024-05-18

4. SUVOREXANT;Prescriber's Guide;2024-04-18

5. Preclinical metabolism and the disposition of vornorexant/TS‐142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomnia;Pharmacology Research & Perspectives;2024-03-15